TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Variants in triggering receptor expressed on myeloid cells 2 (TREM2) confer high risk for Alzheimer’s disease (AD) and other neurodegenerative diseases. However, the cell types and mechanisms underlying TREM2’s involvement in neurodegeneration remain to be established. Here, we report that TREM2 is up-regulated on myeloid cells surrounding amyloid deposits in AD mouse models and human AD tissue. TREM2 was detected on CD45hiLy6C+ myeloid cells, but not on P2RY12+ parenchymal microglia. In AD mice deficient for TREM2, the CD45hiLy6C+ macrophages are virtually eliminated, resulting in reduced inflammation and ameliorated amyloid and tau pathologies. These data suggest a functionally important role for TREM2+ macrophages in AD pathogenesis and an unexpected, detrimental role of TREM2 in AD pathology. These findings have direct implications for future development of TREM2-targeted therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Trem2, a myeloid protein involved in microglial survival and proliferation, regulates a checkpoint necessary for DAM and deletion of Trem2 prevents microglial accumulation around Aβ plaques and leads to additional neuritic damage [6, 14–17].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [14]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“TREM2 was recently demonstrated to be essential for promoting microglial cell association with plaques44–49.”
From Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight (2018) · cites this paper as [45]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Although numerous studies have reported that TREM2 expression is upregulated in amyloid plaque-associated microglia in vivo (Frank et al., 2008; Jay et al., 2015), our research is the first to show that PU.1 knockdown abrogates this phenomenon in vitro.”
From PU.1 dictates β-amyloid-induced TREM2 expression upregulation in microglia in a transgenic model of Alzheimer’s disease (2025) · cites this paper as Jay et al., 2015
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Indeed, manipulation of expression of Trem2, Tyrobp, Cx3cl1/Cx3cr1, IL1β, and IFN-γ have all been shown to have opposing effects on amyloid and tau pathologies [49–51, 55–65].”
From Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways (2022) · cites this paper as [59]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“loss of TREM2 function in AD mouse models restricts the ability of microglia to surround Aβ plaques15,16, proliferate, and convert to DAM10,15,17, which in turn leads to more profound neuritic dystrophy18,19.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [16]
Experimental — accuracy not yet measured
34 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 2×
“5XFAD mice (The Jackson Laboratory B6SJL-Tg(APPSwFlLon,PSEN1*M146*l286V)) express mutant human APP(695) with Swedish (K670N/M671L), Florida (I716V), and London (V717I) mutations and human PSEN1 with M146L and L286V mutations under control of the Thy1 promoter (Oakley et al., 2006).”
BackgroundTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“Notably, variants of the immune cell– specific triggering receptor expressed on myeloid cells 2 (TREM2) confer dramatically elevated risk for developing AD (R. Guerreiro et al., 2013; Jonsson et al., 2013).”
BackgroundIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 3×
“First, we found that TREM2+ cells in AD mouse models 2013; Butovsky et al., 2014), was expressed by parenchymal, nonplaque-associated cells in APPPS1;Trem2+/+ mice (Fig.”
BackgroundSelf-citationIntegrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · cited 2×
“TREM2, along with its obligate intracellular adaptor DAP12, was identified as a hub gene in systems biology analyses in AD (Forabosco et al., 2013; Zhang et al., 2013), highlighting the central importance of these myeloid cell signaling elements CORRESPONDENCE Bruce T.”
BackgroundThe microglial sensome revealed by direct RNA sequencing
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357 · cited 1×
“However, recent genome-wide association studies linked polymorphisms in inflammation-related genes to increased AD risk, supporting the conclusion that inflammation can be a causative factor in disease pathology (Karch and Goate, 2015).”
BackgroundMicroglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329 · cited 1×
“The potential role of peripherally derived macrophages in AD has been controversial (Prinz and Priller, 2014), but it is well accepted that CD45hiLy6C+CCR2+ monocytes enter the central nervous system (CNS) and modulate pathology in other disease contexts (Mildner et al.”
BackgroundWyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Cited by
Items 201–300 of 683
Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities
Yao, H., Coppola, K., Schweig, J. E., Crawford, F., Mullan, M., & Paris, D. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00457 · Cited by 110
Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis
Sheppard, O., & Coleman, M. P. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch1 · Cited by 204
TREM2 triggers microglial density and age-related neuronal loss
Linnartz‐Gerlach, B., Bodea, L., Klaus, C., Ginolhac, A., Halder, R., Sinkkonen, L., Walter, J., Colonna, M., & Neumann, H. (2019) · Glia · doi:10.1002/glia.23563 · Cited by 104
“The fact that TREM2 KO mice do not show an increased gene transcription of Il-1β and/or Tnfα after crossing with different AD mice (Jay et al., 2015; Wang et al., 2015) or after experimental stroke (Sieber et al., 2013) was already observed before.”
BackgroundMiao, J., Chen, L., Pan, X., Li, L.-Q., Zhao, B., & Lan, J. X. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01376-y · Cited by 129
Varvel, N. H., Grathwohl, S. A., Degenhardt, K., Resch, C., Bosch, A., Jucker, M., & Neher, J. J. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150478 · Cited by 99
“Furthermore, recent data indicate that infiltrating monocytes rather than resident microglia express Trem2 (Jay et al., 2015), which would further substantiate a significant role of peripheral myeloid cells in AD pathogenesis.”
BackgroundResultInfluentialSoluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease
Bekris, L. M., Khrestian, M., Dyne, E., Shao, Y., Pillai, J. A., Rao, S. M., Bemiller, S. M., Lamb, B., Fernandez, H. H., & Leverenz, J. B. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.003 · Cited by 99
Self-citationTREM2 is required for microglial instruction of astrocytic synaptic engulfment in neurodevelopment
Jay, T. R., von Saucken, V. E., Muñoz, B., Codocedo, J. F., Atwood, B. K., Lamb, B. T., & Landreth, G. E. (2019) · Glia · doi:10.1002/glia.23664 · Cited by 97
“, 2016) and engage in Aβ-driven phenotypic changes in mouse models of AD (Jay et al., 2015; KerenShaul et al., 2017; Wang et al., 2015).”
BackgroundInfluentialSelf-citationSaber, M., Kokiko-Cochran, O., Puntambekar, S. S., Lathia, J. D., & Lamb, B. T. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2016.4401 · Cited by 95
Self-citationTerzioglu, G., & Young-Pearse, T. L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00674-9 · Cited by 91
Yan, P., Kim, K.-W., Xiao, Q., Ma, X., Czerniewski, L. R., Liu, H., Rawnsley, D. R., Yan, Y., Randolph, G. J., Epelman, S., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci152565 · Cited by 95
Effect of high fat diet on phenotype, brain transcriptome and lipidome in Alzheimer’s model mice
Nam, K. N., Mounier, A., Wolfe, C. M., Fitz, N. F., Carter, A. Y., Castranio, E. L., Kamboh, H. I., Reeves, V. L., Wang, J., Han, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04412-2 · Cited by 94
TREM2 in Alzheimer’s Disease: Microglial Survival and Energy Metabolism
Zheng, H., Cheng, B., Li, Y., Li, X., Chen, X., & Zhang, Y.-W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00395 · Cited by 94
Jendresen, C., Årskog, V., Daws, M. R., & Nilsson, L. N. G. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0835-4 · Cited by 94
“macrophages adjacent to the plaques [6, 7], it is intriguing to think that there might be a connection between Aβ/ApoE complexes and TREM2 on surrounding microglia/macrophages.”
BackgroundInfluentialTaylor, X., Cisternas, P., You, Y., You, Y., Xiang, S., Marambio, Y., Zhang, J., Vidal, R., & Lasagna-Reeves, C. A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01900-7 · Cited by 91
TREM2 suppresses the proinflammatory response to facilitate PRRSV infection via PI3K/NF-κB signaling
Zhu, Z., Zhang, X., Dong, W., Wang, X., he, S. T., Zhang, H., Wang, X., Wei, R., Chen, Y., Liu, X., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008543 · Cited by 104
Effects of Neurological Disorders on Bone Health
Kelly, R. R., Sidles, S. J., & LaRue, A. C. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.612366 · Cited by 96
Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer’s Disease
Marttinen, M., Takalo, M., Natunen, T., Wittrahm, R., Gabbouj, S., Kemppainen, S., Leinonen, V., Tanila, H., Haapasalo, A., & Hiltunen, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00963 · Cited by 88
“However, it should be noted that conflicting data also exist related to the functional outcome measures of TREM2 in mouse models of amyloidosis and tauopathy (Jay et al., 2015; Bemiller et al., 2017; Leyns et al., 2017).”
BackgroundFriend, Foe or Both? Immune Activity in Alzheimer’s Disease
Frost, G. R., Jonas, L. A., & Li, Y.-M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00337 · Cited by 87
Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease
Condello, C., & Stöehr, J. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.03.014 · Cited by 86
“Trem2-knockout in AD mouse models abolishes the stereotypical clustering phenotype of activated microglia surrounding Aβ deposits, but the effects on plaque load are modest and may be stage-dependent (Ulrich et al. 2014, Jay et al. 2015, Wang et al. 2015).”
TREM2‐dependent effects on microglia in Alzheimer's disease
Zhou, Y., Ulland, T. K., & Colonna, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00202 · Cited by 82
“On the contrary, the number of plaque-associated microglia is significantly reduced in Trem2 deficient AD mice, and the effect is Trem2 gene dose-dependent (Jay et al., 2015; Wang et al., 2015).”
BackgroundMethodInfluentialOzaki, Y., Yoshino, Y., Yamazaki, K., Sao, T., Mori, Y., Ochi, S., Yoshida, T., Mori, T., Iga, J., & Ueno, S. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.04.003 · Cited by 91
Pereira, J. B., Janelidze, S., Strandberg, O., Whelan, C. D., Zetterberg, H., Blennow, K., Palmqvist, S., Stomrud, E., Mattsson-Carlgren, N., & Hansson, O. (2022) · Nature Aging · doi:10.1038/s43587-022-00310-z · Cited by 83
Shifting paradigms: The central role of microglia in Alzheimer’s disease
Schwabe, T., Srinivasan, K., & Rhinn, H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104962 · Cited by 84
“Loss of Trem2 in AD mouse models results in a dramatic phenotype characterized by a reduction in microgliosis in response to plaque pathology (Jay et al., 2015; Ulrich et al., 2014; Wang et al., 2015, 2016).”
BackgroundTREM2/DAP12 Complex Regulates Inflammatory Responses in Microglia via the JNK Signaling Pathway
Zhong, L., Zhang, Z.-L., Li, X., Liao, C., Mou, P., Wang, T., Wang, Z., Wang, Z., Wei, M., Xu, H., et al. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00204 · Cited by 83
“The exons 2–4 of the Trem2 gene were replaced with a LacZ reporter which is identical to the line recently reported (Jay et al., 2015).”
MethodDendritic cells in brain diseases
Ludewig, P., Gallizioli, M., Urra, X., Behr, S., Brait, V. H., Gelderblom, M., Magnus, T. U., & Planas, A. M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.11.003 · Cited by 96
Zhu, C., Kros, J. M., van der Weiden, M., Zheng, P., Cheng, C., & Mustafa, D. A. M. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0405-5 · Cited by 81
“The microglial marker Iba-1 is coexpressed with CD45 and is therefore, not discriminative between residential microglia and monocytic cells that migrated into the brain [13].”
Targeting neuroinflammation in Alzheimer’s disease: evidence for NSAIDs and novel therapeutics
Deardorff, W. J., & Grossberg, G. T. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1200972 · Cited by 81
Walter, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.704981 · Cited by 80
“(85) showed decreased A deposition, Wang.”
BackgroundPleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy
Inoue, T., Saitô, S., Tanaka, M., Yamakage, H., Kusakabe, T., Shimatsu, A., Ihara, M., & Satoh‐Asahara, N. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901659116 · Cited by 86
“Furthermore, in a mouse model of AD, TREM2-expressing myeloid cells in the brain were found to be derived from peripheral monocytes and involved in AD pathogenesis (15).”
BackgroundSheng, L., Chen, M., Cai, K., Song, Y., Yu, D., Zhang, H., & Xu, G. (2019) · The FASEB Journal · doi:10.1096/fj.201900527r · Cited by 79
“Previous research has suggested that TREM2 induces microglial clustering around A-b plaques and promotes A-b clearance (12, 15, 16), andTrem2deletion significantly reduces microglial phagocytosis and aggregation of microglia around plaques in a disease-dependent manner (12, 21, 25, 30, 31); interestingly, we also foun…”
BackgroundSelf-citationHigher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration
Franzmeier, N., Suárez-Calvet, M., Frontzkowski, L., Moore, A., Hohman, T. J., Morenas-Rodriguez, E., Nuscher, B., Shaw, L., Trojanowski, J. Q., Dichgans, M., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00407-2 · Cited by 78
Puntambekar, S. S., Saber, M., Lamb, B. T., & Kokiko-Cochran, O. N. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.03.033 · Cited by 76
“peripheral macrophages is associated with TREM2 deficiency in the APPPS1 and 5XFAD mouse models of AD (46) .”
BackgroundSelf-citationAcute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice
Schoch, K. M., Ezerskiy, L. A., Morhaus, M. M., Bannon, R. N., Sauerbeck, A. D., Shabsovich, M., Jafar-nejad, P., Rigo, F., & Miller, T. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100356118 · Cited by 78
“1A), consistent with increased TREM2 expression in other amyloid-depositing mouse models (13, 33, 34) and human AD (35–37).”
BackgroundPeripheral and central neuroimmune mechanisms in Alzheimer’s disease pathogenesis
Zhang, S., Gao, Y., Zhao, Y., Huang, T. Y., Zheng, Q., & Wang, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00812-5 · Cited by 78
“TREM2 + macrophages cluster around amyloid plaques, while TREM2-deficient mice exhibit reduced inflammation and attenuated pathology [59].”
Olfactory dysfunction in the pathophysiological continuum of dementia
Bathini, P., Brai, E., & Auber, L. A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100956 · Cited by 82
“, 2016), triggering receptor expressed on myeloid cells 2 (TREM2) in innate immunity (Fahrenhold et al., 2018; Jay et al., 2015; Shi and Holtzman, 2018), and their convergence as risk variants for sporadic AD, it is likely that an altered inflammatory response to exogenous substances in the airways is transferred thro…”
BackgroundAnwar, S., & Rivest, S. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1738391 · Cited by 77
“While the impact of TREM2 on Aβ deposition remains unclear, studies have reported a decrease in microglial activation in APPPS1-21 and 5xFAD mice that are deficient or haploinsufficient for TREM2, resulting in a corresponding decrease in plaque-associated microglia [74,79].”
BackgroundWhat are activated and reactive glia and what is their role in neurodegeneration?
Bennett, M. L., & Viaene, A. N. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105172 · Cited by 77
Fruhwürth, S., Zetterberg, H., & Paludan, S. R. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578342 · Cited by 74
“Deletion of Trem2 in mouse models of AD reduced initial A β plaque accumulation (Jay et al., 2017; Jay et al., 2015), similar to microglia depletion, but promoted plaque formation at later stages (Jay et al., 2017).”
Targeting autophagy in Alzheimer’s disease: Animal models and mechanisms
Zhang, X.-W., 澳门大学中华医药研究院中药质量研究国家重点实验室, 澳. 凼. 9., State Key Laboratory of Quality Research in Chinese Medicine, I. O. C. M. S., Zhu, X.-X., Tang, D.-S., Lu, J.-H., 佛山大学广东省动物分子设计与精准育种重点实验室, 广., & Guangdong Provincial Key Laboratory of Animal Molecular Design and Precise Breeding, G. E. T. C. O. G. P. (2023) · Zoological Research · doi:10.24272/j.issn.2095-8137.2023.294 · Cited by 77
“Crossing mice carrying TREM2 modifications with those carrying mutant APP genes, such as TREM2 KO/APP/PS1 mice, leads to a reduction in the accumulation of Aβ and tau, suggesting that targeting microglial activity may be a novel therapeutic approach for AD (Jay et al., 2015).”
BackgroundTREM2 expression in the human brain: a marker of monocyte recruitment?
Fahrenhold, M., Rakic, S., Classey, J., Brayne, C., Ince, P. G., Nicoll, J. A. R., Boche, D., & MRC‐CFAS (2018) · Brain Pathology · doi:10.1111/bpa.12564 · Cited by 76
MicroRNA deregulation and chemotaxis and phagocytosis impairment in Alzheimer's disease
Guedes, J. R., Santana, I., Cunha, C., Duro, D., Almeida, M. R., Cardoso, A. M., de Lima, M. C. P., & Cardoso, A. L. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.11.004 · Cited by 76
Kurisu, K., Zheng, Z., Kim, J. Y., Shi, J., Kanoke, A., Liu, J., Hsieh, C. L., & Yenari, M. A. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18817282 · Cited by 74
“It is not expressed in other brain cell types such as neurons, oligodendrocytes or astrocytes.(11,14,16) TREM2 KO mice transplanted with either Wt or KO BM had worse outcomes than Wt mice, even amongst Wt mice transplanted with KO BM.”
BackgroundInfluentialPlaque-associated myeloid cells derive from resident microglia in an Alzheimer's disease model
Reed-Geaghan, E. G., Croxford, A. L., Becher, B., & Landreth, G. E. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191374 · Cited by 72
“We previously argued that the plaque-associated myeloid cells were likely derived from infiltrating peripheral “inflammatory” monocytes, owing to their sustained expression of markers that identify these cells in the blood, i.e., CD45hi and Ly6C, and low levels of the endogenous microglial marker P2RY12 (Jay et al., 2…”
BackgroundSelf-citationRivera-Escalera, F., Pinney, J. J., Owlett, L., Ahmed, H., Thakar, J., Olschowka, J. A., Elliott, M. R., & O’Banion, M. K. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1645-7 · Cited by 75
Castranio, E. L., Hasel, P., Haure‐Mirande, J., Ramirez Jimenez, A. V., Hamilton, B. W., Kim, R. D., Glabe, C. G., Wang, M., Zhang, B., Gandy, S., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12821 · Cited by 80
“49 Support for beneficial outcomes associated with maintenance and/or restoration of homeostatic functions of microglia comes from the numerous studies targeting the members of this pathway, including Trem2, 48,50–52 Tyrobp, 53,54 and miR155.”
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
Uddin, M. S., Kabir, M. T., Jalouli, M., Rahman, M. A., Jeandet, P., Behl, T., Alexiou, A. T., Albadrani, G. M., Abdel‐Daim, M. M., Perveen, A., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210826130210 · Cited by 81
P2X7 as a scavenger receptor for innate phagocytosis in the brain
Gu, B. J., & Wiley, J. S. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14470 · Cited by 74
“Variants of these genes, especially TREM2 and CD33, are associated with compromised phagocytic function of monocytes/macrophages and amyloid Aβ accumulation in AD brains (Bradshaw et al., 2013; Jay et al., 2015).”
BackgroundElder, G. A., Ehrlich, M. E., & Gandy, S. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134294 · Cited by 82
Loss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice
Qu, W., & Li, L. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.2193-20.2020 · Cited by 72
“In AD, complete loss of TREM2 has been shown to affect Ab seeding at early stages but facilitate plaque compaction to limit the spread of Ab later (Jay et al., 2015, 2017; Wang et al., 2015, 2016).”
BackgroundCurrent views on meningeal lymphatics and immunity in aging and Alzheimer’s disease
Rego, S., Sánchez, G., & Mesquita, S. D. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00645-0 · Cited by 82
“There is some consensus, however, regarding the beneficial role of recruited CCR2 + monocytes and brain PVMs in clearing vascular Aβ, despite their apparent lack of interaction with parenchymal Aβ plaques [161, 163, 175–178].”
BackgroundMelchiorri, D., Merlo, S., Micallef, B., Borg, J.-J., & Dráfi, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1196413 · Cited by 70
“An important role could also be played by infiltrating macrophages at some point in the progression of disease, with different functions compared to microglial TREM2 (Jay et al., 2015; Tanzi, 2015).”
BackgroundKoronyo-Hamaoui, M., Sheyn, J., Hayden, E. Y., Li, S., Fuchs, D.-T., Regis, G. C., Lopes, D. H. J., Black, K. L., Bernstein, K. E., Teplow, D. B., et al. (2020) · Brain · doi:10.1093/brain/awz364 · Cited by 70
TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies
Zhang, L., Xiang, X., Li, Y., Bu, G., & Chen, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00834-z · Cited by 97
“Moreover, TREM2 facilitates the clustering of microglia around Aβ plaques, an essential component of the microglial response to amyloid deposition [82–84].”
TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis
Zhou, S.-L., Tan, C.-C., Hou, X.-H., Cao, X.-P., Tan, L., & Yu, J.-T. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-181038 · Cited by 70
Microglia, Trem2, and Neurodegeneration
Shi, Q., Gutierrez, R. A., & Bhat, M. A. (2025) · The Neuroscientist · doi:10.1177/10738584241254118 · Cited by 69
Cellular and Molecular Mediators of Neuroinflammation in Alzheimer Disease
Yang, S.-H. (2019) · International Neurourology Journal · doi:10.5213/inj.1938184.092 · Cited by 68
“Further compelling evidence that compromised microglial function elevates the risk of AD through mis-regulation of the inflammatory response comes from studies identifying a rare mutation in the extracellular domain of TREM2 [30-32].”
BackgroundInfluentialTrem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
Fitz, N. F., Wolfe, C. M., Playso, B. E., Biedrzycki, R. J., Lu, Y., Nam, K. N., Lefterov, I., & Koldamova, R. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00394-4 · Cited by 68
“The effect of TREM2 on amyloid deposition in AD mice is controversial, however, with some studies showing the lack of TREM2 increasing [25, 26] and others decreasing the amyloid load [19, 22].”
BackgroundOhara, T., Hata, J., Tanaka, M., Honda, T., Yamakage, H., Yoshida, D., Inoue, T., Hirakawa, Y., Kusakabe, T., Shibata, M., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25385 · Cited by 69
Microglial toll-like receptors and Alzheimer’s disease
Su, F., Bai, F., Zhou, H., & Zhang, Z. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.10.010 · Cited by 71
“Secondly, emerging evidence has demonstrated the detrimental effects of anti-inflammatory factors, such as TREM2 and IL-10, on AD pathology (Chakrabarty et al., 2015; Jay et al., 2015), which implies that neuroinflammation is more complex than was previously appreciated.”
Cui, Y., Chen, C., Tang, Z., Yuan, W., Yue, K., Cui, P., Qiu, X., Zhang, H., Li, T., Zhu, X., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06756-w · Cited by 79
Laroni, A., de Rosbo, N. K., & Uccelli, A. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.08.007 · Cited by 71
“macrophages/microglial cells have been associated to the risk of AD and other neurodegenerative diseases [80], although its role in the disease is controversial [81-82].”
BackgroundLow-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer’s Disease
Kim, S.-J., Chung, H., Mai, H. N., Nam, Y., Shin, S. J., Park, Y., Chung, M. J., Lee, J. K., Rhee, H. Y., Jahng, G., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124532 · Cited by 70
Audrain, M., Haure‐Mirande, J., Mleczko, J., Wang, M., Griffin, J. K., St George‐Hyslop, P. H., Fraser, P., Zhang, B., Gandy, S., & Ehrlich, M. E. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12256 · Cited by 65
Delizannis, A. T., Nonneman, A., Tsering, W., De Bondt, A., Van den Wyngaert, I., Zhang, B., Meymand, E., Olufemi, M. F., Koivula, P., Maimaiti, S., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01251-1 · Cited by 65
“Although prior studies [22, 46] have examined the effect of TREM2 KO on Aβ plaque formation, with evidence of increased plaque burden in older 5XFAD × TREM2 KO mice relative to control 5XFAD mice, these studies did not differentiate male and female mice.”
BackgroundResultInfluentialCarrasquillo, M. M., Allen, M., Burgess, J. D., Wang, X., Strickland, S. L., Aryal, S., Siuda, J., Kachadoorian, M. L., Medway, C., Younkin, C. S., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.10.005 · Cited by 58
Hebron, M. L., Peyton, M. A., Liu, X., Gao, X., Wang, R., Lonskaya, I., & Moussa, C. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.07.009 · Cited by 76
Reassessment of Pioglitazone for Alzheimer’s Disease
Saunders, A. M., Burns, D. K., & Gottschalk, W. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.666958 · Cited by 63
Agadjanyan, M. G., Petrovsky, N., & Ghochikyan, A. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.06.1884 · Cited by 64
Woodling, N. S., & Andreasson, K. I. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00016 · Cited by 63
Behavioral and transcriptomic analysis of Trem2-null mice: not all knockout mice are created equal
Kang, S. S., Kurti, A., Baker, K. E., Liu, C.-C., Colonna, M., Ulrich, J. D., Holtzman, D. M., Bu, G., & Fryer, J. D. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx366 · Cited by 62
“using Trem2 / mice from Velocigene targeting or Colonna lab targeting have revealed alterations in the clustering and morphology of plaque associated myeloid or microglial cells (34,46,57).”
MethodResultMicroglial Function and Regulation during Development, Homeostasis and Alzheimer’s Disease
Casali, B. T., & Reed-Geaghan, E. G. (2021) · Cells · doi:10.3390/cells10040957 · Cited by 78
“Solely expressed on microglia in the CNS [93], TREM2 signaling mediates both the elimination of synapses by microglia and synapse engulfment via astrocytes during development and homeostasis [42,43].”
BackgroundPan-SHIP1/2 inhibitors promote microglia effector functions essential for CNS homeostasis
Pedicone, C., Fernandes, S., Dungan, O. M., Dormann, S. M., Viernes, D. R., Adhikari, A. A., Choi, L. B., De Jong, E. P., Chisholm, J. D., & Kerr, W. G. (2020) · Journal of Cell Science · doi:10.1242/jcs.238030 · Cited by 61
Xu, Y., Au, N. P. B., & Ma, C. H. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.896852 · Cited by 70
Dengler-Crish, C. M., Smith, M. A., & Wilson, G. N. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160658 · Cited by 61
“Of added interest, an increasing number of studies are addressing the role of triggering receptor expressed on myeloid cells 2 (TREM2) in AD [17], which is expressed in bone cells as well as the central nervous system (CNS) [18], since mutations in this immune modulator have been linked to several conditions character…”
BackgroundHigh TREM2 expression correlates with poor prognosis in gastric cancer
Zhang, X., Wang, W. T., Li, P., Wang, X., & Ni, K. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.10.026 · Cited by 63
Novel targets in Alzheimer’s disease: A special focus on microglia
Balducci, C., & Forloni, G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.017 · Cited by 66
Dhandapani, R., Neri, M., Bernhard, M., Brzak, I., Schweizer, T., Rudin, S., Joller, S., Berth, R., Kernen, J., Neuhaus, A., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110883 · Cited by 60
Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease
Ghosh, S., & Geahlen, R. L. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.09.053 · Cited by 59
“The myeloid receptor TREM2 functionally associates with TYROBP and promotes the internalization of bacteria and apoptotic neurons and recruits MG to Aβ plaques (N'Diaye et al., 2009; Takahashi et al., 2005, Wang et al., 2015; Jay et al., 2015).”
BackgroundDivergent Neuroinflammatory Regulation of Microglial TREM Expression and Involvement of NF-κB
Owens, R., Grabert, K., Davies, C. L., Alfieri, A., Antel, J. P., Healy, L. M., & McColl, B. W. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00056 · Cited by 54
“Elevated TREM2 gene or protein expression has been reported in animal models of chronic neurodegeneration (Jay et al., 2015; Wang et al., 2015) and in human post-mortem AD tissue (Lue et al.”
BackgroundMethodInfluentialChemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
Zuena, A. R., Casolini, P., Lattanzi, R., & Maftei, D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00622 · Cited by 60
Dengler-Crish, C. M., Ball, H. C., Lin, L., Novak, K. M., & Cooper, L. N. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.021 · Cited by 58
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47H
Kotredes, K. P., Oblak, A., Pandey, R. S., Lin, P. B.-C., Garceau, D., Williams, H., Uyar, A., O’Rourke, R., O’Rourke, S., Ingraham, C., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.735524 · Cited by 66
Self-citationPlaque contact and unimpaired Trem2 is required for the microglial response to amyloid pathology
Wood, J. I., Wong, E., Joghee, R., Balbaa, A., Vitanova, K. S., Stringer, K. M., Vanshoiack, A., Phelan, S.-L. J., Launchbury, F., Desai, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111686 · Cited by 58
“The observation that Trem2 and related genes are strongly upregulated as plaques deposit in AD is well documented in studies of both mouse models(6,13) and human postmortem tissue.(3,35) Moreover, it has been repeatedly observed that the response of microglia around plaques is dependent on the Trem2 genotype and is de…”
BackgroundReview: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease
Ameen‐Ali, K. E., Wharton, S. B., Simpson, J. E., Heath, P. R., Sharp, P., & Berwick, J. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12440 · Cited by 60
Karahan, H., Smith, D. C., Kim, B., Dabin, L. C., Al-Amin, M. M., Wijeratne, H. R. S., Pennington, T., Viana di Prisco, G., McCord, B., Lin, P. B.-C., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe3954 · Cited by 53
Myeloid Cells in Alzheimer's Disease: Culprits, Victims or Innocent Bystanders?
Meyer‐Luehmann, M., & Prinz, M. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.011 · Cited by 59
Castranio, E. L., Mounier, A., Wolfe, C. M., Nam, K. N., Fitz, N. F., Letronne, F., Schug, J., Koldamova, R., & Lefterov, I. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.05.006 · Cited by 56
Oussini, H. E., Bayer, H., Scekic‐Zahirovic, J., Vercruysse, P., Sinniger, J., Dirrig‐Grosch, S., Dieterle, S., Echaniz‐Laguna, A., Larmet, Y., Müller, K., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1534-4 · Cited by 65
“However, recent work demonstrated that loss of Trem2 leads either to microglial degeneration in different diseases of the central nervous system [55,66,11], or conversely to protection [34].”
BackgroundTriggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma
Peshoff, M., Gupta, P., Oberai, S., Trivedi, R., Katayama, H. G., Chakrapani, P., Dang, M., Migliozzi, S., Gumin, J., Kadri, D. B., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noad257 · Cited by 62
Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease
Zhao, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03031-9 · Cited by 66
“The upregulated TREM2 was observed on Aβ-triggered microglia in AD patients and transgenic AD murine models [118].”
BackgroundTan, Y. J., Ng, A. S. L., Vipin, A., Lim, J. K. W., Chander, R. J., Ji, F., Qiu, Y., Ting, S. K. S., Hameed, S., Lee, T.-S., et al. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-161277 · Cited by 55
“This contrasts with previous reports where TREM2-positive microglia appeared to express the peripheral myeloid cell marker CD45 and lack the brain microglia P2RY12, suggesting their peripheral origin [45, 48].”
BackgroundResultLILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00550-y · Cited by 54
“This stage-dependent effect of LILRB2 in AD is consistent with the perplexing roles that TREM2 plays in AD [85, 86].”
ResultCosker, K., Mallach, A., Limaye, J., Piers, T. M., Staddon, J., Neame, S. J., Hardy, J., & Pocock, J. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-91207-1 · Cited by 54
Sleep Disruption Exacerbates and Prolongs the Inflammatory Response to Traumatic Brain Injury
Tapp, Z. M., Kumar, J. E., Witcher, K. G., Atluri, R. R., Velasquez, J., O’Neil, S. M., Dziabis, J. E., Bray, C. E., Sheridan, J. F., Godbout, J. P., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7010 · Cited by 57
Imaging of Leukocyte Trafficking in Alzheimer’s Disease
Pietronigro, E., Zenaro, E., & Constantin, G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00033 · Cited by 53
“Furthermore, recent data indicate that infiltrating monocytes rather than resident microglia express TREM2, a receptor involved in myeloid cell phagocytosis, further supporting the role of peripheral myeloid cells in AD pathogenesis (14).”
BackgroundBlood-Based Biomarkers of Neuroinflammation in Alzheimer’s Disease: A Central Role for Periphery?
Angiulli, F., Conti, E., Zoia, C. P., Da Re, F., Appollonio, I., Ferrarese, C., & Tremolizzo, L. (2021) · Diagnostics · doi:10.3390/diagnostics11091525 · Cited by 52
TREM2 and Risk of Alzheimer’s Disease — Friend or Foe?
Tanzi, R. E. (2015) · New England Journal of Medicine · doi:10.1056/nejmcibr1503954 · Cited by 52
Amo‐Aparicio, J., Garcia-Garcia, J., Francos-Quijorna, I., Urpi, A., Esteve‐Codina, A., Gut, M., Quintana, A., & López‐Vales, R. (2021) · Theranostics · doi:10.7150/thno.65203 · Cited by 55
“ameliorated Aβ deposition and Tau pathology, and prevented neuronal death in an acute model of neurodegeneration [36,52].”
BackgroundPopescu, A. S., Butler, C. A., Allendorf, D. H., Piers, T. M., Mallach, A., Roewe, J., Reinhardt, P., Cinti, A., Redaelli, L., Boudesco, C., et al. (2023) · Glia · doi:10.1002/glia.24318 · Cited by 49
“TREM2 expression has been shown to be upregulated in microglia that associate with amyloid plaques in Alzheimer's disease (AD) (Brendel et al., 2017; Giraldo et al., 2013; Jay et al., 2015; Yuan et al., 2016).”
BackgroundSmart, C. D., Fehrenbach, D. J., Wassenaar, J. W., Agrawal, V., Fortune, N. L., Dixon, D., Cottam, M. A., Hasty, A. H., Hemnes, A. R., Doran, A. C., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad093 · Cited by 59
Metadata
- Authors
- Jay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., Cotleur, A. C., Butovsky, O., Bekris, L., Staugaitis, S. M., Leverenz, J. B., Pimplikar, S. W., Landreth, G. E., Howell, G. R., Ransohoff, R. M., & Lamb, B. T.
- Affiliations
- Cleveland Clinic (US)
- The Lerner Research Institute 1 and 2
- Jackson Laboratory (US)
- Case Western Reserve University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Lamb, Bruce T.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2015-03-02
- Volume
- 212
- Issue
- 3
- Pages
- 287-295
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4354365
- OpenAlex
- W2155344647
- Cited by
- 682
- References
- 33
- Citations by year
- 2026: 27 · 2025: 56 · 2024: 46 · 2023: 56 · 2022: 74 · 2021: 62 · 2020: 70 · 2019: 59 · 2018: 65 · 2017: 67 · 2016: 54 · 2015: 45
- FWCI
- 41.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (UL1TR000439)
- National Institute on Aging (R01AG023012, AG023012, F31AG048704)
- National Institute of General Medical Sciences (T32GM007250)
- National Institute of Neurological Disorders and Stroke (NS047804, T32NS067431, NS087298, R01NS088137, T32NS077888)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- TREM2, Alzheimer's disease, inflammatory macrophages, microglia, amyloid deposits, tau pathology, neuroinflammation, amyloidosis
- MeSH terms
- Age Factors, Aged, Alzheimer Disease, Animals, Disease Models, Animal, Female, Hippocampus, Humans, Macrophages, Male, Membrane Glycoproteins, Mice, Transgenic, Receptors, Immunologic, Up-Regulation, Amyloid beta-Peptides, tau Proteins, Leukocyte Common Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.